Comments on: Why do prescription medications cost so much more in the U.S. than Canada?

By: Obamacare to cause huge increase in premiums for many - Page 10 - Christian Forums

Fri, 18 Jan 2013 10:28:51 +0000

[...] you like to compare the price of pharmaceuticals in America as compared to the rest of the world? Why do prescription medications cost so much more in the U.S. than Canada? | eDrugSearch Blog __________________ It matters not how strait the gate, How charged with punishments the [...]

By: J. V.

J. V. — Tue, 23 Nov 2010 22:18:42 +0000

The facts are it is simply greed. The drug lobbies have pull on the politicians. No controls are set in place for price. While any compnay deserves to make a fair profit for thier product, they should not be allowed to rape the public. It’s just what the oil companies do. They make billions in profits. If their profits drop by a couple of million they start crying poverty. The point is they are still making “profit”. Alos, I never understand why it falls upon U.S. citizens alone to flip the bill for the R&D. If the cost of this expensive part of drug making was evenly shared globally, drugs would be much more affordable for everyone any the companies could sillmake a fair profit. It’s all about $$.

By: Big Pharma Cuts R&D | The eDrugSearch Blog

Big Pharma Cuts R&D | The eDrugSearch Blog — Tue, 09 Feb 2010 01:56:37 +0000

[...] they get rid of the cost of research and development, what excuse will big pharma have left to overcharge consumers?SHARETHIS.addEntry({ title: "Big [...]

By: iGuide

iGuide — Thu, 14 May 2009 22:17:03 +0000

Another sad aspect of drug pricing is that drug companies are more tempted to develop the most profitable medications, instead focusing of the ones needed to save lives. For example, we have seen a recent influx of expensive drugs for erectile dysfunction. Also, the drug companies seek the most profit, that is selling at a high price which only a smaller portion of consumers are willing to pay, because that is more profitable than selling at a lower price which more people can afford. But, the current system leaves many unwilling to spend on health care (either out of inability or disgust for the system) and the rest throwing too much of their earnings (either themselves, or via their employers mind-bogglingly-high payments) at medicine. I think even having to talk about this kind of nonsense is silly, we so badly need price controls in the United States that its not even funny anymore.

By: George

George — Fri, 20 Mar 2009 16:56:22 +0000

Dan is correct that there are entirely too many “me too” drugs on the market — Why, because physicians will prescribe based on what is detailed to them by Pharma, not what is the best and most economical product. A prime example: Prilosec, a great drug for acid reflux, as it was approved to go over the counter, Nexium was released by the same company and exclusively marketed to physicians, minimal, if any significant improvements, but patients who were not having any problems taking Prilosec were switched to Nexium. Many of these examples can be found — if a patient has been stable on a generic, why switch to something new, just because it is now available? If we stop prescribing the “me toos”, industry will be forced to stop making them and focus on the un treated needs.

By: Fool Me Once, Shame on You « The Facts and Foibles of Cybermedicine

Fool Me Once, Shame on You « The Facts and Foibles of Cybermedicine — Sat, 18 Oct 2008 21:48:12 +0000

[...] either! CBS aired a report in 2002 that exposed a popular scam in Canada. Prescription drugs are cheaper in Canada than in the United States. Hence, it seems logical that Americans turn their attention to [...]

By: Dan

Dan — Sun, 09 Mar 2008 23:16:19 +0000

The U.S. does not pay but a fraction of the R&D costs of thier meds. The NIH often does the actual research, so in essence, a patient is paying for a med twice from a big pharma company. Other reasons include the development of numerous and unnecessary ‘me too’ drugs by big pharma, which reasonably should lower the price of that particular class of medication, but instead, and with great elation, keeps the price of these copies at the price of the others, because that is what the market will bear for the benefit of thier shareholders.